Todd Minga
Senior Vice President of Research & DevelopmentDr. Todd Minga, MD, is Senior Vice President of Research & Development of SCYNEXIS, Inc. from September 14, 2026. He brings more than two decades of experience spanning clinical medicine, drug development, medical affairs, clinical research and strategic leadership in kidney disease and rare disorders. He joins SCYNEXIS from Akebia Therapeutics, where he most recently served as Vice President, Medical Affairs and Clinical Development. In that role, he helped shape clinical and regulatory strategies, support pipeline advancement, engage with regulators and key opinion leaders and contribute to business development initiatives. Prior to Akebia, Dr. Minga held leadership positions at Maze Therapeutics, IQVIA and practiced as a board-certified nephrologist for more than 16 years. Dr. Minga earned his Doctor of Medicine degree from Eastern Virginia Medical School and completed his residency in Internal Medicine and fellowship in Nephrology at the University of Alabama at Birmingham. He is board certified in Internal Medicine and Nephrology and has authored numerous scientific publications in kidney disease and related therapeutic areas.
Positions
- Company NameSCYNEXIS, Inc.Stock CodeSCYXPositionSenior Vice President of Research & DevelopmentColleagues
- DGDavid Gonzalez AnguloCEO, President & Director
- GMGuy MacDonaldIndependent Chairman of the Board
- SSScott SukenickChief Legal Officer & Corporate Secretary
- SSSanjay S. SubramanianChief Financial Officer
- DGDaniella GiganteVice President of Human Resources & Information Technology
- AFAnn F. HanhamIndependent Director
- DCDavid C. HastingsIndependent Director
- AAArmando AnidoIndependent Director
